Lee, F. C., Harris, W., Cheng, H. H., Shenoi, J., Zhao, S., Wang, J., . . . Wright, J. L. Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer. Wiley.
Chicago Style (17th ed.) CitationLee, Franklin C., et al. Pathologic Response Rates of Gemcitabine/Cisplatin Versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer. Wiley.
MLA (9th ed.) CitationLee, Franklin C., et al. Pathologic Response Rates of Gemcitabine/Cisplatin Versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer. Wiley.
Warning: These citations may not always be 100% accurate.